Fact CheckerSign in

NCT05752383Recruiting

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Source: ClinicalTrials.gov · Last updated 2 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit. This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock. The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
24 Jan 2023
Start date
24 Jan 2023
Primary completion date
Jan 2028
Lead sponsor
Centre Hospitalier Universitaire, Amiens
NCT number
NCT05752383

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 24 Jan 2023 to the primary completion date, Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient with cardiogenic shock in the context of septic shock and hemorrhagic shock

Who the study is looking for

  • Patients hospitalized in ICU for cardiogenic shock
  • Patient with cardiogenic shock as defined by the FRENSCHOCK2 study criteria

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chu Amiens Picardie
Coordinator of this site? Confirm its status
AmiensFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.